Trial Profile
Study 007: Bioavailability of MGCD 290 Under Fed Versus Fasting Conditions in Healthy Female Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Dec 2012
Price :
$35
*
At a glance
- Drugs MGCD 290 (Primary)
- Indications Vulvovaginal candidiasis
- Focus Pharmacokinetics
- 24 Dec 2012 New trial record